In The News,
Lindsay Bealor Greenleaf discusses the President’s Medicaid prescription drug proposals with Modern Healthcare
[el-text]
Written by Virgil Dickson
Monday, 12 February 2018
“This type of policy change would break the bargain that Congress struck in the 1990s that requires states to provide coverage for every FDA-approved drug in exchange for Medicaid drug rebates,” Republican healthcare analyst Lindsay Bealor Greenleaf, director at consultancy ADVI, said in a statement.
[/el-text]